Form 4: Phillips Bryan K reports disposition transactions in INSP

Rhea-AI Filing Summary

Phillips Bryan K reported disposition transactions in a Form 4 filing for INSP. The filing lists transactions totaling 327 shares at a weighted average price of $66.33 per share. Following the reported transactions, holdings were 13,070 shares.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Phillips Bryan K

Role See Remarks

Type	Security	Shares	Price	Value
Tax Withholding	Common Stock	327	$66.33	$22K

Holdings After Transaction: Common Stock — 13,070 shares (Direct)

Footnotes (1)

1. Reflects shares of common stock that were withheld by the Issuer to satisfy taxes incident to vesting of a performance stock unit award. Includes (i) 67 shares acquired under the Inspire Medical Systems, Inc. 2018 Employee Stock Purchase Plan (the "Plan") on June 30, 2025 and (ii) 94 shares acquired under the Plan on December 31, 2025.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Phillips Bryan K

(Last) (First) (Middle)

C/O INSPIRE MEDICAL SYSTEMS, INC.

5500 WAYZATA BLVD., SUITE 1600

(Street)

GOLDEN VALLEY MN 55416

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Inspire Medical Systems, Inc. [ INSP ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	See Remarks

3. Date of Earliest Transaction (Month/Day/Year)
02/09/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/09/2026		F		327(1)	D	$66.33	13,070(2)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Reflects shares of common stock that were withheld by the Issuer to satisfy taxes incident to vesting of a performance stock unit award.

2. Includes (i) 67 shares acquired under the Inspire Medical Systems, Inc. 2018 Employee Stock Purchase Plan (the "Plan") on June 30, 2025 and (ii) 94 shares acquired under the Plan on December 31, 2025.

Remarks:

Senior Vice President, General Counsel, Secretary and Chief Compliance Officer

	/s/ Bryan Phillips	02/11/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did INSP officer Bryan Phillips report on February 9, 2026?

Bryan K. Phillips reported a tax-withholding disposition of 327 shares of Inspire Medical Systems common stock on February 9, 2026. The shares were withheld by the company to satisfy taxes from a vesting performance stock unit award.

Was the INSP Form 4 transaction an open market sale of shares?

No, the Form 4 shows a tax-withholding disposition coded “F,” not an open market sale. Shares were withheld by Inspire Medical Systems to cover tax liabilities from a vesting performance stock unit award granted to the executive.

How many Inspire Medical Systems shares does Bryan Phillips own after this Form 4?

After the reported tax-withholding disposition, Bryan K. Phillips directly beneficially owned 13,070 shares of Inspire Medical Systems common stock. This figure reflects the remaining holdings following the 327 shares withheld for tax purposes.

What role does Bryan Phillips hold at Inspire Medical Systems (INSP)?

Bryan K. Phillips serves as Senior Vice President, General Counsel, Secretary and Chief Compliance Officer at Inspire Medical Systems. His Form 4 filing reflects equity-related activity tied to his executive compensation, including performance stock unit vesting.

What does transaction code “F” mean in the INSP Form 4 filing?

Transaction code “F” in this Form 4 indicates payment of a tax liability by delivering securities. For INSP, 327 shares of common stock were withheld by the issuer to satisfy taxes due when a performance stock unit award vested.

How were additional INSP shares previously acquired by Bryan Phillips under the ESPP?

The filing notes that his holdings include 67 shares acquired under the 2018 Employee Stock Purchase Plan on June 30, 2025, and 94 shares acquired under the same plan on December 31, 2025, highlighting ongoing participation in the company’s purchase program.